CARDINAL HEALTH INC business relationships

“Our largest customer, CVS Health, accounted for 28 percent of our fiscal 2026 revenue.” SEC filing

“Red Oak Sourcing, LLC ("Red Oak Sourcing"), a U.S.-based generic pharmaceutical sourcing venture with CVS Health, negotiates generic pharmaceutical supply contracts on behalf of both companies.” SEC filing

“Our pharmaceutical distribution contracts with OptumRx expired at the end of June 2024.” SEC filing

“During fiscal 2025, net cash provided by operating activities was $2.4 billion, which includes the impact of unwinding the negative net working capital associated with the OptumRx contracts and the normal timing of payments to vendors, partially offset by the benefit of onboarding new customers.” SEC filing

“Our two largest GPO relationships in terms of revenue are with Vizient, Inc. and Premier, Inc. Sales to” SEC filing

“...ics program includes, among other things, the impact of generic pharmaceutical product launches, customer volumes, pricing changes, the Red Oak Sourcing, LLC venture ("Red Oak Sourcing") with CVS Health Corporation ("CVS Health"), and generic pharmaceutical contract manufacturing and sourcing costs.” SEC filing

“Red Oak Sourcing, LLC ("Red Oak Sourcing"), a U.S.-based generic pharmaceutical sourcing venture with CVS Health, negotiates generic pharmaceutical supply contracts on behalf of both companies.” SEC filing

“Our product sales to three large wholesalers, McKesson Corporation, Cencora, Inc. and Cardinal Health, Inc., each individually accounted for more than 10% of total revenues for each of the years 2025, 2024 and 2023.” SEC filing

“Under the Distribution Agreement, we provide Cardinal Health with forecasts of the volume of our products to be handled and distributed by Cardinal Health.” SEC filing

“Historically, approximately 90% of our gross product sales in the U.S. have been to three wholesalers-Cardinal Health, Inc., Cencora, Inc. and McKesson Corporation-and their specialty distributor affiliates.” SEC filing

“The Company's customers with the largest accounts receivable balances are: McKesson Corporation, Cencora, Inc. and Cardinal Health, Inc., which represented approximately 22 %, 21 % and 13 %, respectively, of total accounts receivable at December 31, 2025.” SEC filing

“The sales to Cencora Group, McKesson Group and Cardinal Health Group were JPY 579,065 million, JPY 578,767 million and JPY 436,951 million, respectively, for the year ended March 31, 2024.” SEC filing

“For the year ended December 31, 2025, our four largest customers, Cencora, Inc., McKesson Drug Co., Cardinal Health, Inc., and CVS Health Corporation, collectively accounted for approximately 71% of our consolidated net revenue.” SEC filing

“For example, large wholesalers and retailer customers have formed alliances, such as Walgreens and Cencora, Inc., Rite Aid and McKesson Drug Company, and CVS Caremark and Cardinal Health.” SEC filing

“In 2025, 2024, and 2023, three wholesale distributors in the U.S.-McKesson Corporation, Cencora, Inc., and Cardinal Health, Inc.-each accounted for a significant percentage of our consolidated revenue.” SEC filing

“In addition, we rely heavily on the three largest pharmaceutical wholesalers in the U.S. market-Cardinal Health Inc., Cencora, and McKesson Corp-in the distribution of ARISTADA and ARISTADA INITIO, LYBALVI and VIVITROL.” SEC filing

“We conduct business with the three major wholesalers in the U.S.: Cencora, Inc., Cardinal Health, and McKesson.” SEC filing

“VWR International, LLC, Cardinal Health, Inc. and Medline Industries Inc. are also distributors of our products.” SEC filing

“The Company has Distribution Services Agreements ("DSAs") with several large wholesale customers such as McKesson Corporation, Cencora Inc., Cardinal Health, Inc. and McKesson Specialty.” SEC filing

“Our primary wholesale distributor relationships currently include Cardinal Health, Inc., McKesson Corporation, Smith Drug Company, and Morris and Dickson Co. L.L.C., in addition to various generic drug manufacturers.” SEC filing

“We had three wholesalers each comprising 10 percent or more of our total revenue for the year ended December 31, 2025: McKesson Drug Company, Cardinal Health, Inc. and AmerisourceBergen Health Corporation, which accounted for 31%, 26% and 22% of our total revenues, respectively.” SEC filing

“...drop-ship program under which orders are processed through wholesalers (including AmerisourceBergen Health Corporation, Cardinal Health, Inc. and McKesson Drug Company), but shipments of the product are sent directly to individual accounts, such as hospitals, ambulatory surgery centers and individua...” SEC filing

“distribute Illuccix , including partnerships with Cardinal Health, Inc., PharmaLogic Holdings, Corp., and Jubilant Pharma” SEC filing

“AUCATZYL is manufactured at our dedicated commercial manufacturing site, the Nucleus, in Stevenage, U.K. We intend for the Nucleus to meet the global supply demands of AUCATZYL, with Cardinal Health 105, LLC serving as our commercial distribution partner in the US.” SEC filing

“During the year ended December 31, 2025, approximately 99% of LOQTORZI revenues were from three large wholesale distributors: McKesson Corporation , Cencora, Inc., and Cardinal Health, Inc.” SEC filing

“In 2025, Cardinal Health Specialty Solutions exclusively handled our U.S. product logistics activities, including warehousing, shipping, and various other customer activities.” SEC filing

“Our specialty distributor network sells to hospitals, physician practices and other sites of care and consists of McKesson, ASD/Oncology Supply, Cardinal Health, DMS Pharmaceutical Group and Bio Care.” SEC filing

“Each of our three major customers, Cencora, Inc., Cardinal Health, Inc., and McKesson Corporation, individually accounted for more than 15% of our total product revenue in 2025 and collectively accounted for more than 76% of our total product revenue in 2025.” SEC filing

“In 2025, three wholesale distributors (McKesson Corporation, Cardinal Health, Inc. and Cencora, Inc.) accounted for substantially all of AbbVie's pharmaceutical product sales in the United States.” SEC filing

“In the years ended December 31, 2020, and 2021, and in the first quarter of 2022, Cardinal Health 105 was our only customer and sales to Cardinal Health 105 represented all of our net revenue for such periods.” SEC filing

“We may be unable to control the timing of the delivery of ZTlido, ELYXYB and GLOPERBA to distributors, and any financial uncertainty or loss of key logistic employees of Cardinal Health 105, as our only third-party logistics provider, may negatively impact our sales.” SEC filing

“In April 2022, we discontinued our use of "title model" services provided by Cardinal Health 105 but expect that Cardinal Health 105 will continue to perform other third-party logistics services for us.” SEC filing

“We also utilize third parties for the commercial distribution of Auryxia and Vafseo, including Cardinal Health, Inc. as the exclusive third-party logistics provider, or 3PL , wholesale distributors and certain specialty pharmacy providers.” SEC filing

“For contracts with Cardinal Health, a single performance obligation is satisfied at a point in time upon each contract's Free On Board ("FOB") terms when control, including title and all risks, has transferred to the customer.” SEC filing

“In addition, Citius Oncology has entered into distribution agreements with Cardinal Health, Cencora and McKesson” SEC filing

“For example, for the fiscal year ended September 30, 2025, gross sales to Cencora, McKesson Corporation, and Cardinal Health, Embecta's three largest distributors, together represented approximately 42% of Embecta's worldwide gross sales.” SEC filing

“For the fiscal year ended September 30, 2025, McKesson Corporation, Cardinal Health and Cencora, Embecta's three largest distributors, together represented approximately 42% of Embecta's worldwide gross sales.” SEC filing

“four pharmaceutical product wholesaler distributors: McKesson Corporation, Cencora Inc., Western Wellness and Cardinal Health, Inc. These” SEC filing

“LYMPHIR, we have entered into distribution agreements with Cardinal Health, Cencora and McKesson Corporation.” SEC filing

“Additionally, other distributors of med-surg products similarly connect the fragmented supplier and provider bases and aggregate inventory from suppliers to deliver products to customers, such as McKesson, Cardinal Health, Owens & Minor, and Henry Schein.” SEC filing